Published in Nature on March 06, 2013
CD133 Transplantation to Generate Oocytes in Poor Ovarian Reserve | NCT01966536
Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell (2013) 2.81
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat Cell Biol (2014) 2.65
Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun (2015) 1.35
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res (2014) 1.12
Recent concepts of ovarian carcinogenesis: type I and type II. Biomed Res Int (2014) 1.11
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget (2015) 1.07
Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer. J Pathol (2013) 1.06
Current status and evolution of preclinical drug development models of epithelial ovarian cancer. Front Oncol (2013) 0.98
Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention. Mol Cancer (2014) 0.94
miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Rep (2014) 0.94
Opportunistic salpingectomy: the way forward-response to Steven Narod. Curr Oncol (2013) 0.93
Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms. Front Oncol (2013) 0.91
It's Totally Tubular…Riding The New Wave of Ovarian Cancer Research. Cancer Res (2015) 0.90
Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. Sci Rep (2015) 0.89
Transcriptional mutagenesis and its potential roles in the etiology of cancer and bacterial antibiotic resistance. J Cell Physiol (2013) 0.89
Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance. Mol Pharm (2014) 0.89
Article by Natalie Banet and Robert J. Kurman: Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis; Int. J. Gynecol. Pathol. 2015;34:3-8. Int J Gynecol Pathol (2015) 0.89
A matrix metalloproteinase mediates long-distance attenuation of stem cell proliferation. J Cell Biol (2014) 0.89
Reliable in vitro studies require appropriate ovarian cancer cell lines. J Ovarian Res (2014) 0.89
FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Oncotarget (2016) 0.89
CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget (2015) 0.86
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer. Oncotarget (2016) 0.86
Targeting the tumour microenvironment in ovarian cancer. Eur J Cancer (2016) 0.86
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population. Front Oncol (2014) 0.86
In vitro enrichment of ovarian cancer tumor-initiating cells. J Vis Exp (2015) 0.86
Ovary and fimbrial stem cells: biology, niche and cancer origins. Nat Rev Mol Cell Biol (2015) 0.86
Stem cells, progenitor cells, and lineage decisions in the ovary. Endocr Rev (2014) 0.86
The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium. J Pathol (2014) 0.86
Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers. Mol Cell Oncol (2014) 0.86
Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients. Hum Mol Genet (2013) 0.85
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Res (2015) 0.84
Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor. Oncotarget (2013) 0.84
Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2. Proc Natl Acad Sci U S A (2015) 0.82
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling. Oncogene (2015) 0.81
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer. Front Oncol (2017) 0.81
Ovarian LGR5 is critical for successful pregnancy. FASEB J (2014) 0.80
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Mol Cancer Res (2014) 0.80
Novel Action of FSH on Stem Cells in Adult Mammalian Ovary Induces Postnatal Oogenesis and Primordial Follicle Assembly. Stem Cells Int (2015) 0.80
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer. Cancer Res (2016) 0.79
New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Transl Res (2016) 0.79
Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma. J Pathol (2014) 0.79
Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer. J Ovarian Res (2016) 0.79
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma. Mod Pathol (2014) 0.79
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis. Mol Cancer (2013) 0.79
Preventing ovarian cancer by salpingectomy. Curr Oncol (2013) 0.78
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome. Genome Biol (2016) 0.78
Ovarian adult stem cells: hope or pitfall? J Ovarian Res (2014) 0.78
Tubal origin of ovarian low-grade serous carcinoma. Am J Clin Exp Obstet Gynecol (2013) 0.78
Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis. Int J Clin Exp Pathol (2014) 0.78
miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition. Front Pharmacol (2016) 0.77
Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse. J Pathol (2016) 0.77
Ovarian stem cells: From basic to clinical applications. World J Stem Cells (2015) 0.77
A reliable parameter to standardize the scoring of stem cell spheres. PLoS One (2015) 0.77
Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer. Med Oncol (2016) 0.77
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer. Onco Targets Ther (2016) 0.77
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. Fam Cancer (2015) 0.77
A new mitochondrial pool of cyclin E, regulated by Drp1, is linked to cell-density-dependent cell proliferation. J Cell Sci (2015) 0.76
Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas. Gastric Cancer (2015) 0.76
Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer. Sci Rep (2016) 0.76
Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. JCI Insight (2016) 0.76
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex. Sci Rep (2016) 0.76
Effects of deletion of the transcription factor Nrf2 and benzo [a]pyrene treatment on ovarian follicles and ovarian surface epithelial cells in mice. Reprod Toxicol (2015) 0.76
Wnt target genes and where to find them. F1000Res (2017) 0.75
Stem cells: Anatomy of an ovarian cancer. Nature (2013) 0.75
Ovarian hormones through Wnt signalling regulate the growth of human and mouse ovarian cancer initiating lesions. Oncotarget (2016) 0.75
Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole. Int J Exp Pathol (2016) 0.75
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. J Transl Med (2013) 0.75
Altered (neo-) lacto series glycolipid biosynthesis impairs α2-6 sialylation on N-glycoproteins in ovarian cancer cells. Sci Rep (2017) 0.75
Ovarian cancer: At the starting line. Nat Rev Cancer (2013) 0.75
Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells. Int J Mol Sci (2016) 0.75
De-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGFβ-deficient squamous cell carcinoma from transition zones. Elife (2017) 0.75
Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget (2017) 0.75
Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients. Oncotarget (2016) 0.75
Non-neoplastic Fallopian Tube Epithelium Carrying Gene Mutations of a Novel SOX2 Repressor Region is Soil of High-grade Serous Ovarian Cancer. EBioMedicine (2016) 0.75
Inactivation of Retinoblastoma Protein (Rb1) in the Oocyte: Evidence That Dysregulated Follicle Growth Drives Ovarian Teratoma Formation in Mice. PLoS Genet (2015) 0.75
Ovarian cancer stem cells: still an elusive entity? Mol Cancer (2017) 0.75
HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation. Am J Cancer Res (2017) 0.75
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues. J Cell Mol Med (2016) 0.75
Transplantation Into the Mouse Ovarian Fat Pad. J Vis Exp (2016) 0.75
Subtypes of Ovarian Cancer and Ovarian Cancer Screening. Diagnostics (Basel) (2017) 0.75
Pathways to Genome-targeted Therapies in Serous Ovarian Cancer. J Nat Sci (2017) 0.75
LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions. Mod Pathol (2017) 0.75
High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease. J Pathol (2017) 0.75
The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment. Stem Cells Int (2017) 0.75
LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer. Cell Death Dis (2017) 0.75
Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma. Nat Genet (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci (2009) 21.94
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol (2010) 7.27
Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell (2010) 7.25
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
Cells of origin in cancer. Nature (2011) 6.85
Ovarian cancer development and metastasis. Am J Pathol (2010) 5.92
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol (2010) 5.23
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res (2007) 4.95
Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A (2006) 4.54
Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc (2009) 4.47
Epithelial stem cells: turning over new leaves. Cell (2007) 4.10
The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer (2010) 4.06
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91
The cell of origin of ovarian epithelial tumours. Lancet Oncol (2008) 3.74
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol (1999) 3.59
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One (2010) 3.38
Strategies for homeostatic stem cell self-renewal in adult tissues. Cell (2011) 3.33
miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol (2011) 2.79
Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells (2005) 2.67
Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature (2011) 2.59
Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res (2003) 2.58
Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells (2007) 2.50
Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods (2006) 2.43
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res (2006) 2.23
The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol (2011) 1.76
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem Pharmacol (1988) 1.56
The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol (2011) 1.47
Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res (2007) 1.41
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc Natl Acad Sci U S A (2008) 1.41
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A (2011) 1.36
Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res (2012) 1.30
The origin of ovarian carcinomas: a developmental view. Gynecol Oncol (2008) 1.26
Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice. Genes Dev (1996) 1.22
Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency. Am J Pathol (2010) 1.06
Expression of enzymes synthesizing (aldehyde dehydrogenase 1 and reinaldehyde dehydrogenase 2) and metabolizaing (Cyp26) retinoic acid in the mouse female reproductive system. Endocrinology (2000) 0.99
Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis (2007) 0.90
Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice. Cancer Res (2005) 0.84
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature (2010) 15.28
Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation. Proc Natl Acad Sci U S A (2003) 8.92
Endothelial and perivascular cells maintain haematopoietic stem cells. Nature (2012) 6.60
Neural stem and progenitor cells in nestin-GFP transgenic mice. J Comp Neurol (2004) 5.22
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res (2007) 4.95
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell (2010) 4.30
Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus. Cell Stem Cell (2011) 4.08
Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science (2007) 3.96
Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A (2006) 3.39
Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol (2004) 3.36
Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci U S A (2003) 3.07
Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res (2003) 3.04
Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature (2012) 2.73
Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res (2003) 2.58
c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A (2012) 2.35
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res (2006) 2.23
Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res (2010) 2.19
Phenotypic and functional characterization of adult brain neuropoiesis. Proc Natl Acad Sci U S A (2005) 2.08
Intermediate progenitors in adult hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal output. J Neurosci (2008) 2.05
Nestin-GFP reporter expression defines the quiescent state of skeletal muscle satellite cells. Dev Biol (2006) 1.94
ΔNp63α is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell (2011) 1.75
Identifying and quantitating neural stem and progenitor cells in the adult brain. Methods Cell Biol (2008) 1.72
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res (2004) 1.67
Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc Natl Acad Sci U S A (2008) 1.64
Progenitor cells of the testosterone-producing Leydig cells revealed. J Cell Biol (2004) 1.60
Genetic approaches identify adult pituitary stem cells. Proc Natl Acad Sci U S A (2008) 1.58
Neural potential of a stem cell population in the hair follicle. Cell Cycle (2007) 1.53
The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev Biol (2012) 1.50
Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A (2003) 1.42
Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res (2007) 1.41
Brain maturation in neonatal rodents is impeded by sevoflurane anesthesia. Anesthesiology (2015) 1.38
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A (2011) 1.36
Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle (2008) 1.35
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res (2007) 1.33
From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest (2007) 1.32
Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy. Transl Oncol (2010) 1.31
Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res (2003) 1.30
Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms. Cancer Res (2008) 1.26
Do-it-yourself (DIY) pathology. Nat Biotechnol (2008) 1.23
Nitric oxide activates diverse signaling pathways to regulate gene expression. J Biol Chem (2003) 1.22
Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res (2006) 1.22
Neurogenic hippocampal targets of deep brain stimulation. J Comp Neurol (2011) 1.19
The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells (2009) 1.17
Moderate traumatic brain injury promotes proliferation of quiescent neural progenitors in the adult hippocampus. Exp Neurol (2009) 1.16
Identification of radiation-specific responses from gene expression profile. Oncogene (2002) 1.16
ARF mutation accelerates pituitary tumor development in Rb+/- mice. Proc Natl Acad Sci U S A (2002) 1.15
Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci U S A (2012) 1.12
Expression of nestin-green fluorescent protein transgene marks oval cells in the adult liver. Dev Dyn (2005) 1.11
Advancing translational research. Science (2011) 1.11
Circumventricular organs: a novel site of neural stem cells in the adult brain. Mol Cell Neurosci (2009) 1.08
Primary cilia regulate proliferation of amplifying progenitors in adult hippocampus: implications for learning and memory. J Neurosci (2011) 1.07
Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency. Am J Pathol (2010) 1.06
EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc Natl Acad Sci U S A (2010) 1.05
A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity. Nat Neurosci (2013) 1.04
FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappaB. Arterioscler Thromb Vasc Biol (2007) 1.03
MicroRNA and ovarian cancer. Histol Histopathol (2008) 1.03
PTEN is a potent suppressor of small cell lung cancer. Mol Cancer Res (2014) 1.02
Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. Horm Cancer (2010) 1.01
Essential function of nitric oxide synthase in Drosophila. Curr Biol (2004) 1.00
Quiescent adult neural stem cells are exceptionally sensitive to cosmic radiation. Exp Neurol (2007) 0.99
Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Cancer Gene Ther (2003) 0.98
Training mouse pathologists: five years of pathology of mouse models of human disease workshops. Toxicol Pathol (2007) 0.97
Pro-neural transcription factors as cancer markers. BMC Med Genomics (2008) 0.97
Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease. Kidney Int (2004) 0.96
Transient elevation of adult hippocampal neurogenesis after dopamine depletion. Exp Neurol (2010) 0.96
Use of multiphoton imaging for studying cell migration in the mouse. Methods Mol Biol (2005) 0.95
Microtome-free 3-dimensional confocal imaging method for visualization of mouse intestine with subcellular-level resolution. Gastroenterology (2009) 0.94
Regulation of the intermediate filament protein nestin at rodent neuromuscular junctions by innervation and activity. J Neurosci (2007) 0.93
A microfluidic traps system supporting prolonged culture of human embryonic stem cells aggregates. Biomed Microdevices (2010) 0.92
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis (2007) 0.92
Neuronal nitric oxide synthase contributes to the regulation of hematopoiesis. Mol Med (2008) 0.92
Role of p53 and Rb in ovarian cancer. Adv Exp Med Biol (2008) 0.91
Three-dimensional optical method for integrated visualization of mouse islet microstructure and vascular network with subcellular-level resolution. J Biomed Opt (2010) 0.90
Nitric oxide is a regulator of hematopoietic stem cell activity. Mol Ther (2004) 0.90
Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis (2007) 0.90
MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Cell Cycle (2011) 0.90
Regulation of multimers via truncated isoforms: a novel mechanism to control nitric-oxide signaling. Genes Dev (2004) 0.89
Precancer in mice: animal models used to understand, prevent, and treat human precancers. Toxicol Pathol (2006) 0.88
Cytokine regulation networks in the cancer microenvironment. Front Biosci (2008) 0.88
Selection of neural differentiation-specific genes by comparing profiles of random differentiation. Stem Cells (2006) 0.87
Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer. Chin J Integr Med (2013) 0.87
Toxicity and biomedical imaging of layered nanohybrids in the mouse. Toxicol Pathol (2007) 0.87
Extracellular matrix proteases - cytokine regulation role in cancer and pregnancy. Front Biosci (Landmark Ed) (2009) 0.86
Mouse models for cancer stem cell research. Toxicol Pathol (2009) 0.86
Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep (2005) 0.85
Dominant activation of the hedgehog signaling pathway alters development of the female reproductive tract. Genesis (2011) 0.85
Cloning and expression of a phenylalanine ammonia-lyase gene (BoPAL2) from Bambusa oldhamii in Escherichia coli and Pichia pastoris. Protein Expr Purif (2010) 0.84
Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice. Cancer Res (2005) 0.84
Direct isolation of neural stem cells in the adult hippocampus after traumatic brain injury. J Neurotrauma (2008) 0.84
Nitric oxide mediates local activity-dependent excitatory synapse development. Proc Natl Acad Sci U S A (2013) 0.83
Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models. J Control Release (2012) 0.83
Cul4B regulates neural progenitor cell growth. BMC Neurosci (2012) 0.83
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis (2006) 0.83
Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. PLoS One (2013) 0.82
Molecular characterization of a phenylalanine ammonia-lyase gene (BoPAL1) from Bambusa oldhamii. Mol Biol Rep (2010) 0.82